FDA Rejects Vaginal Pain Treatment
A Florida-based health care company on Monday said that the U.S. Food and Drug Administration has rejected its new drug application for a treatment aimed at vaginal pain during sexual intercourse...To view the full article, register now.
Already a subscriber? Click here to view full article